AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH)
businesswire.com
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in